Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$267000.0.

  • AtriCure's Income towards Parent Company rose 9660.0% to -$267000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.8 million, marking a year-over-year increase of 2607.21%. This contributed to the annual value of -$44.7 million for FY2024, which is 4684.93% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Income towards Parent Company is -$267000.0, which was up 9660.0% from -$6.2 million recorded in Q2 2025.
  • AtriCure's 5-year Income towards Parent Company high stood at $97.1 million for Q3 2021, and its period low was -$16.9 million during Q1 2021.
  • Its 5-year average for Income towards Parent Company is -$4.5 million, with a median of -$9.1 million in 2023.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first soared by 206217.42% in 2021, then plummeted by 13474.82% in 2023.
  • Over the past 5 years, AtriCure's Income towards Parent Company (Quarter) stood at -$13.7 million in 2021, then surged by 69.65% to -$4.2 million in 2022, then tumbled by 134.75% to -$9.8 million in 2023, then plummeted by 59.04% to -$15.6 million in 2024, then soared by 98.28% to -$267000.0 in 2025.
  • Its Income towards Parent Company stands at -$267000.0 for Q3 2025, versus -$6.2 million for Q2 2025 and -$6.7 million for Q1 2025.